Twice each month the CEA Registry Blog lists recently published cost utility studies and associated papers. 17 papers were listed this time. Here's a few in our areas of research interest:
Liew D, De Abreu Lourenço R, Adena M, et al. Cost-Effectiveness of 12-Month Treatment With Ticagrelor Compared With Clopidogrel in the Management of Acute Coronary Syndromes. Clin Ther. 2013 Jul 26. [Epub ahead of print] PubMed PMID: 23891361.
Parthan A, Kruse M, Yurgin N, et al. Cost Effectiveness of Denosumab versus Oral Bisphosphonates for Postmenopausal Osteoporosis in the US. Appl Health Econ Health Policy. 2013 Jul 19. [Epub ahead of print] PubMed PMID: 23868102.
Nshimyumukiza L, Duplantie J, Gagnon M, et al. Dabigatran versus warfarin under standard or pharmacogenetic-guided management for the prevention of stroke and systemic thromboembolism in patients with atrial fibrillation: a cost/utility analysis using an analytic decision model. Thromb J. 2013 Jul 17;11(1):14. [Epub ahead of print] PubMed PMID: 23866305.
